ArticleCardiovascular diabetology2023

The cardiovascular and renal effects of glucagon-like peptide 1 receptor agonists in patients with advanced diabetic kidney disease.

Yuan Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.